Skip to main contentSkip to navigationSkip to search
ENZY  
SEK  %
Logotype
ENZY  
SEK  %
Logotype

Media

Press releases

2024

September 12, 2024 - Regulatory press release
Enzymatica announces outcome of new rights issue
September 9, 2024 - Regulatory press release
Enzymatica publishes supplementary prospectus
September 5, 2024 - Regulatory press release
Reported results on secondary endpoints from the University of Kent study on ColdZyme® show significant reduction of symptoms, lost training days and viral load
August 26, 2024 - Regulatory press release
Publication of prospectus regarding Enzymatica’s rights issue
August 16, 2024 - Regulatory press release
Final results from independent clinical study of ColdZyme® show duration of illness lowered by approximately 5 days.
August 6, 2024 - Regulatory press release
Bulletin from the extraordinary general meeting of Enzymatica AB (publ) on 6 August 2024
July 18, 2024 - Regulatory press release
Interim report Q2/2024: Enzymatica builds momentum for expansion
July 18, 2024 - Regulatory press release
Enzymatica's Board of Directors updates the financial targets
July 18, 2024 - Regulatory press release
Notice of Extraordinary General Meeting in Enzymatica AB (publ)
July 18, 2024 - Regulatory press release
Enzymatica’s Board of Directors decides on a new rights issue of approximately SEK 130 million
June 13, 2024 - Regulatory press release
Interim results from independent clinical study of ColdZyme® show duration of illness lowered by approximately 5 days
May 7, 2024 - Regulatory press release
Bulletin from annual general meeting of Enzymatica AB (publ) on May 7, 2024
April 25, 2024 - Regulatory press release
Interim report Q1/2024: MDR certification opens up great commercial opportunities
April 9, 2024 - Regulatory press release
Enzymatica publishes annual report for 2023
March 27, 2024 - Regulatory press release
Notice of Annual General Meeting 2024 in Enzymatica AB (publ)
March 14, 2024 - Regulatory press release
Enzymatica announces outcome of new rights issue
March 11, 2024 - Non-regulatory press release
ColdZyme® certified under the new EU medical device regulation (MDR)
February 19, 2024 - Regulatory press release
Enzymatica publishes information memorandum about rights issue of shares
February 16, 2024 - Regulatory press release
Enzymatica’s rights issue is secured to 100 percent
February 16, 2024 - Regulatory press release
Year-end report 2023: Scientific and regulatory progress generating international interest
Load more